Non-opioid antinociception produced by brain stem injections of improgan: Significance of local, but not cross-regional, cannabinoid mechanisms

Brain Research

Volumn 1247, Issue , 2009, Pages 62-70

  Hough, Lindsay B ^a   Svokos, Konstantina ^a   Nalwalk, Julia W ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Analgesia; Cannabinoid; Improgan; Pain; Periaqueductal gray; Rimonabant

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; HISTAMINE H2 RECEPTOR ANTAGONIST; IMPROGAN; RIMONABANT; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESPONSE; HOT PLATE TEST; LATENT PERIOD; MALE; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAPHE MAGNUS NUCLEUS; RAT; TAIL FLICK TEST;

ANALGESICS; ANIMALS; BENZOXAZINES; BRAIN STEM; CIMETIDINE; ENDOCANNABINOIDS; MALE; MICROINJECTIONS; MORPHOLINES; NAPHTHALENES; NEURAL PATHWAYS; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY; PIPERIDINES; PYRAZOLES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RHOMBENCEPHALON;

RATTUS;

EID: 57349086245     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.10.008     Document Type: Article

References (43)

1. Blair R., Cytryniak P., Shizgal P., and Amit Z. Naloxone's antagonism of rigidity, but not explosive motor behavior: possible evidence for two types of mechanisms underlying the actions of opiates and opioids. Behav. Biol. 24 (1978) 24-31
2. Caille S., and Parsons L.H. Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway. Neuropsychopharmacology 31 (2006) 804-813
3. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29 (2006) 37-76
4. Crane L.A., and Glick S.D. Simple cannula for repeated intracerebral drug administration in rats. Pharmacol. Biochem. Behav. 10 (1979) 799-800
5. D'Amour F.E., and Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72 (1941) 74-79
6. Eddy N.B., and Leimbach D. Synthetic analgesics. II. Dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107 (1953) 385-393
7. Finn D.P., Jhaveri M.D., Beckett S.R., Roe C.H., Kendall D.A., Marsden C.A., and Chapman V. Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology 45 (2003) 594-604
8. Gehani N.C., Nalwalk J.W., Razdan R.K., Martin B.R., Sun X., Wentland M., Abood M.E., and Hough L.B. Significance of cannabinoid CB(1) receptors in improgan antinociception. J. Pain 8 (2007) 850-860
9. Heinricher M.M., and Ingram S.L. The brainstem and nociceptive modulation. In: Basbaum A.I., Bushnell M.C., and Julius D. (Eds). The Senses: a Comprehensive Reference. Vol. 3: Pain (2008), Elsevier, New York
10. Hohmann A.G., Suplita R.L., Bolton N.M., Neely M.H., Fegley D., Mangieri R., Krey J.F., Walker J.M., Holmes P.V., Crystal J.D., Duranti A., Tontini A., Mor M., Tarzia G., and Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature 435 (2005) 1108-1112
11. Hough L.B. Improgan-like analgesics: a family of compounds derived from histamine antagonists. Med. Chem. Res. 13 (2004) 78-87
12. Hough L.B., Nalwalk J.W., Chen Y., Schuller A., Zhu Y., Zhang J., Menge W.M.P.B., Leurs R., Timmerman H., and Pintar J.E. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice. Brain Res. 880 (2000) 102-108
13. Hough L.B., Nalwalk J.W., Menge W.M., Leurs R., and Timmerman H. Significance of GABAergic systems in the action of improgan, a non-opioid analgesic. Life Sci. 68 (2001) 2751-2757
14. Hough L.B., Nalwalk J.W., Stadel R., Timmerman H., Leurs R., Paria B.C., Wang X., and Dey S.K. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-p yrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors. J. Pharmacol. Exp. Ther. 303 (2002) 314-322
15. Hough L.B., Nalwalk J.W., Lu Q., Shan Z., Svokos K., Wentland M.P., and Montero M.J. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic. Eur. J. Pharmacol. 522 (2005) 38-46
16. Hough L.B., De Esch I.J., Janssen E., Phillips J., Svokos K., Kern B., Trachler J., Abood M.E., Leurs R., and Nalwalk J.W. Antinociceptive activity of chemical congeners of improgan: optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic. Neuropharmacology 51 (2006) 447-456
17. Hough L.B., Menge W.M., van de Stolpe A.C., Nalwalk J.W., Leurs R., and De Esch I.J. Antinociceptive activity of furan-containing congeners of improgan and ranitidine. Bioorg. Med. Chem. Lett. 17 (2007) 5715-5719
18. 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3093-3098
19. Jacquet Y.F., and Squires R.F. Excitatory amino acids: role in morphine excitation in rat periaqueductal gray. Behav. Brain Res. 31 (1988) 85-88
20. Jacquet Y.F., Klee W.A., Rice K.C., Iijima I., and Minamikawa J. Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?. Science 198 (1977) 842-845
21. Kiefel J.M., Rossi G.C., and Bodnar R.J. Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624 (1993) 151-161
22. LaBella F.S., Pinsky C., and Havlicek V. Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity. Brain Res. 174 (1979) 263-271
23. Li B.Y., Nalwalk J.W., Barker L.A., Cumming P., Parsons M.E., and Hough L.B. Characterization of the antinociceptive properties of cimetidine and a structural analog. J. Pharmacol. Exp. Ther. 276 (1996) 500-508
24. Li B.Y., Nalwalk J.W., Finkel J.M., Glick S.D., and Hough L.B. SKF92374, a cimetidine analog, produces mechanical and thermal antinociception in the absence of motor impairment. Analgesia 3 (1997) 15-20
25. Martin W.J., Patrick S.L., Coffin P.O., Tsou K., and Walker J.M. An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sci. 56 (1995) 2103-2109
26. Martin W.J., Tsou K., and Walker J.M. Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett. 242 (1998) 33-36
27. Mobarakeh J.I., Nalwalk J.W., Watanabe T., Sakurada S., Hoffman M., Leurs R., Timmerman H., Silos-Santiago I., Yanai K., and Hough L.B. Improgan antinociception does not require neuronal histamine or histamine receptors. Brain Res. 974 (2003) 146-152
28. 1 receptor mediated analgesia from the Nucleus Reticularis Gigantocellularis pars alpha is activated in an animal model of neuropathic pain. Brain Res. 908 (2001) 67-74
29. Morgan M.M., Depaulis A., and Leibeskind J.C. Diazepam dissociates the analgesic and aversive effects of periaqueductal gray stimulation in the rat. Brain Res. 423 (1987) 395-398
30. Morgan M.M., Whitney P.K., and Gold M.S. Immobility and flight associated with antinociception produced by activation of the ventral and lateral/dorsal regions of the rat periaqueductal gray. Brain Res. 804 (1998) 159-166
31. Nalwalk J.W., Svokos K., Taraschenko O., Leurs R., Timmerman H., and Hough L.B. Activation of brain stem nuclei by improgan, a non-opioid analgesic. Brain Res. 1021 (2004) 248-255
32. Nalwalk J.W., Svokos K., and Hough L.B. Cannabinoid-improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB(1) receptor. Eur. J. Pharmacol. 549 (2006) 79-83
33. Pan Z.Z., and Fields H.L. Endogenous opioid-mediated inhibition of putative pain-modulating neurons in rat rostral ventromedial medulla. Neuroscience 74 (1996) 855-862
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, Sydney
35. 1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. Psychopharmacology (Berl) 198 (2008) 405-411
36. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., Soubrie P., Breliere J.C., and Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56 (1995) 1941-1947
37. Salussolia C.L., Nalwalk J.W., and Hough L.B. Improgan-induced hypothermia: A role for cannabinoid receptors in improgan-induced changes in nociceptive threshold and body temperature. Brain Res. 1152 (2007) 42-48
38. Schmitt P., Carrive P., Di Scala G., Jenck F., Brandao M., Bagri A., Moreau J.-L., and Sandner G. A neuropharmacological study of the periventricular neural substrate involved in flight. Behav. Brain Res. 22 (1986) 181-190
39. Succu S., Mascia M.S., Melis T., Sanna F., Boi A., Melis M.R., and Argiolas A. Morphine reduces penile erection induced by the cannabinoid receptor antagonist SR 141617A in male rats: role of paraventricular glutamic acid and nitric oxide. Neurosci. Lett. 404 (2006) 1-5
40. Suplita R.L., Farthing J.N., Gutierrez T., and Hohmann A.G. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Neuropharmacology 49 (2005) 1201-1209
41. 2 adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic. Brain Res. 921 (2001) 12-19
42. Taylor B.K., and Basbaum A.I. Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray. J. Neurochem. 86 (2003) 1129-1141
43. Yaksh T.L., Yeung J.C., and Rudy T.A. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res. 114 (1976) 83-103